Vertex Pharmaceuticals Incorporated (VRTX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 11.73B | 11.2B | 10.57B | 10.43B | 10.01B | 9.6B | 9.8B | 8.94B | 13.29B | 14.14B | 14.7B | 13.87B | 12.97B | 13.23B | 12.27B | 11.5B | 10.36B | 9.56B | 8.85B | 8.46B |
| Cash & Short-Term Investments | 7.25B | 6.61B | 6.29B | 6.38B | 6.2B | 6.12B | 6.52B | 5.8B | 10.17B | 11.22B | 11.93B | 11.24B | 10.41B | 10.78B | 9.77B | 9.25B | 8.24B | 7.52B | 6.96B | 6.71B |
| Cash Only | 5.49B | 5.09B | 4.94B | 4.97B | 4.67B | 4.57B | 5.24B | 4.58B | 9.16B | 10.37B | 11.11B | 10.15B | 9.29B | 10.5B | 9.17B | 8.7B | 7.6B | 6.79B | 6.28B | 6.06B |
| Short-Term Investments | 1.75B | 1.52B | 1.35B | 1.41B | 1.53B | 1.55B | 1.29B | 1.22B | 1.01B | 849.2M | 818M | 1.09B | 1.12B | 274.5M | 599.2M | 551.2M | 638M | 729.9M | 685.19M | 644.32M |
| Accounts Receivable | 2B | 2.05B | 1.95B | 1.89B | 1.81B | 1.61B | 1.75B | 1.66B | 1.79B | 1.56B | 1.54B | 1.56B | 1.55B | 1.44B | 1.39B | 1.33B | 1.29B | 1.14B | 1.1B | 929.14M |
| Days Sales Outstanding | 61 | 57.01 | 57.42 | 56.76 | 55.47 | 53.08 | 56.53 | 59.32 | 56.83 | 56.68 | 57.32 | 56.65 | 56.66 | 56.48 | 53.56 | 54.4 | 52.12 | 49.65 | 47.05 | 48.38 |
| Inventory | 1.77B | 1.69B | 1.63B | 1.5B | 1.36B | 1.21B | 1.08B | 914.6M | 813.1M | 738.8M | 688.7M | 603.5M | 535.1M | 460.6M | 388.2M | 367.7M | 338.9M | 353.1M | 333.46M | 321.62M |
| Days Inventory Outstanding | 395.64 | 327.09 | 346.67 | 319.23 | 317.99 | 248.27 | 233.68 | 211.38 | 206.1 | 178.44 | 186.51 | 167.88 | 167.88 | 137.82 | 120.15 | 122.8 | 126.69 | 127.65 | 127.41 | 123.84 |
| Other Current Assets | 720.8M | 748.6M | 709.4M | 652.3M | 642.8M | 206.5M | 449.2M | 575.4M | 511.1M | 86.1M | 540.2M | 476.9M | 468.7M | 121.9M | 0 | 0 | 0 | 103.7M | 0 | 0 |
| Total Non-Current Assets | 14.75B | 14.94B | 14.29B | 13.61B | 12.87B | 12.94B | 12.44B | 11.19B | 10.63B | 8.59B | 7.03B | 6.48B | 6.01B | 4.92B | 4.44B | 4.08B | 3.89B | 3.87B | 3.77B | 3.76B |
| Property, Plant & Equipment | 1.61B | 3.08B | 3.02B | 2.65B | 2.63B | 2.58B | 2.51B | 1.77B | 1.49B | 1.45B | 1.43B | 1.45B | 1.45B | 1.46B | 1.46B | 1.42B | 1.44B | 1.42B | 1.35B | 1.34B |
| Fixed Asset Turnover | 1.27x | 1.06x | 1.09x | 1.12x | 1.06x | 1.14x | 1.29x | 1.62x | 1.83x | 1.74x | 1.72x | 1.72x | 1.64x | 1.58x | 1.62x | 1.54x | 1.47x | 1.49x | 1.47x | 1.36x |
| Goodwill | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B | 1.08B | 1B | 1B | 1B | 1B | 1B |
| Intangible Assets | 418.5M | 424.2M | 429.8M | 435.5M | 441.2M | 825.9M | 831.6M | 837.5M | 834.9M | 839.9M | 603.6M | 603.6M | 603.6M | 603.6M | 603.6M | 387M | 400M | 400M | 400M | 400M |
| Long-Term Investments | 5.75B | 5.81B | 5.72B | 5.65B | 5.16B | 5.11B | 4.7B | 4.39B | 4.38B | 2.5B | 1.7B | 1.36B | 1.08B | 112.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.94B | 1.14B | 1.1B | 1.08B | 1.01B | 999.3M | 990.2M | 915.6M | 875.7M | 895.3M | 475.2M | 442.7M | 427.5M | 409.6M | 132.5M | 127.3M | 110.7M | 110.8M | 75.52M | 71.1M |
| Total Assets | 26.48B | 26.14B | 24.86B | 24.04B | 22.88B | 22.53B | 22.24B | 20.13B | 23.92B | 22.73B | 21.73B | 20.35B | 18.97B | 18.15B | 16.71B | 15.58B | 14.26B | 13.43B | 12.62B | 12.22B |
| Asset Turnover | 0.11x | 0.13x | 0.13x | 0.13x | 0.12x | 0.13x | 0.13x | 0.12x | 0.12x | 0.11x | 0.12x | 0.13x | 0.13x | 0.13x | 0.14x | 0.15x | 0.15x | 0.16x | 0.16x | 0.15x |
| Asset Growth % | 15.75% | 16.02% | 11.79% | 19.39% | -4.34% | -0.87% | 2.37% | -1.07% | 26.05% | 25.23% | 30.05% | 30.59% | 33.1% | 35.13% | 32.39% | 27.5% | 17.67% | 14.3% | 11.65% | 19.63% |
| Total Current Liabilities | 3.88B | 3.86B | 4.48B | 4.14B | 3.78B | 3.56B | 3.97B | 3.55B | 3.8B | 3.55B | 3.6B | 3.35B | 3.03B | 2.74B | 2.61B | 2.56B | 2.18B | 2.14B | 1.91B | 1.84B |
| Accounts Payable | 489.3M | 461.7M | 4.03B | 442.3M | 445M | 413M | 395.8M | 327.9M | 351.4M | 364.9M | 375.9M | 363M | 323.2M | 303.9M | 126.9M | 198M | 173.6M | 195M | 127.86M | 127.53M |
| Days Payables Outstanding | 108.95 | 443.76 | 496.39 | 99.07 | 106.36 | 87.87 | 84.79 | 83.11 | 95.13 | 92.6 | 106.65 | 101.17 | 105.73 | 69.95 | 51.64 | 64.58 | 67.48 | 60.03 | 49.67 | 50.97 |
| Short-Term Debt | 0 | 82.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 171.8M | 0 | 0 | 0 | 206.8M | 0 | 0 | 0 | 170.3M | 0 | 0 | 0 | 159.6M | 0 | 0 | 0 | 171.7M | 0 | 0 |
| Other Current Liabilities | 407.1M | 2.75B | 441.5M | 425.4M | 386.4M | 31.4M | 357.6M | 279.3M | 648.6M | 50.7M | 316.2M | 391M | 377M | 62.5M | 218M | 238.7M | 286.1M | 16.5M | 201.41M | 226.36M |
| Current Ratio | 3.02x | 2.90x | 2.36x | 2.52x | 2.65x | 2.69x | 2.47x | 2.52x | 3.50x | 3.99x | 4.08x | 4.14x | 4.28x | 4.83x | 4.70x | 4.50x | 4.75x | 4.46x | 4.62x | 4.61x |
| Quick Ratio | 2.57x | 2.46x | 2.00x | 2.16x | 2.29x | 2.35x | 2.20x | 2.26x | 3.29x | 3.78x | 3.89x | 3.96x | 4.11x | 4.66x | 4.55x | 4.36x | 4.60x | 4.30x | 4.45x | 4.43x |
| Cash Conversion Cycle | 347.69 | -59.66 | -92.29 | 276.92 | 267.09 | 213.48 | 205.42 | 187.59 | 167.81 | 142.51 | 137.19 | 123.35 | 118.8 | 124.35 | 122.07 | 112.62 | 111.33 | 117.28 | 124.79 | 121.25 |
| Total Non-Current Liabilities | 3.24B | 3.62B | 3.07B | 2.72B | 2.6B | 2.56B | 2.64B | 1.81B | 1.57B | 1.6B | 1.61B | 1.53B | 1.52B | 1.5B | 1.07B | 1.09B | 1.17B | 1.19B | 1.17B | 1.19B |
| Long-Term Debt | 0 | 1.85B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.99B | 1.95B | 1.83B | 1.53B | 1.65B | 1.66B | 1.7B | 933.4M | 721.3M | 724.7M | 744.7M | 767.6M | 789.2M | 810.3M | 824.6M | 847.3M | 872.5M | 887.2M | 876.8M | 893.85M |
| Deferred Tax Liabilities | 0 | 1.31B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.26B | -1.49B | 1.23B | 1.2B | 951.9M | 901.8M | 933.3M | 876.8M | 853.6M | 877.7M | 869.3M | 759.3M | 726.5M | 685.8M | 242.9M | 245.2M | 296.4M | 303.3M | 296.97M | 294.99M |
| Total Liabilities | 7.12B | 7.48B | 7.54B | 6.86B | 6.38B | 6.12B | 6.61B | 5.36B | 5.37B | 5.15B | 5.21B | 4.88B | 4.54B | 4.24B | 3.68B | 3.65B | 3.35B | 3.33B | 3.09B | 3.03B |
| Total Debt | 1.99B | 3.88B | 1.83B | 1.53B | 1.65B | 1.75B | 1.7B | 933.4M | 721.3M | 808.4M | 744.7M | 767.6M | 789.2M | 899.7M | 824.6M | 847.3M | 872.5M | 967.4M | 876.8M | 893.85M |
| Net Debt | -3.51B | -1.21B | -3.1B | -3.44B | -3.03B | -2.82B | -3.54B | -3.65B | -8.44B | -9.56B | -10.37B | -9.38B | -8.5B | -9.6B | -8.35B | -7.85B | -6.73B | -5.83B | -5.4B | -5.17B |
| Debt / Equity | 0.10x | 0.21x | 0.11x | 0.09x | 0.10x | 0.11x | 0.11x | 0.06x | 0.04x | 0.05x | 0.05x | 0.05x | 0.05x | 0.06x | 0.06x | 0.07x | 0.08x | 0.10x | 0.09x | 0.10x |
| Debt / EBITDA | 1.75x | 2.87x | 1.48x | 1.27x | 2.43x | 1.63x | 1.46x | - | 0.60x | 0.77x | 0.69x | 0.72x | 0.97x | 0.84x | 0.71x | 0.74x | 0.81x | 1.06x | 0.81x | - |
| Net Debt / EBITDA | -3.08x | -0.89x | -2.50x | -2.86x | -4.46x | -2.63x | -3.02x | - | -7.07x | -9.13x | -9.60x | -8.79x | -10.39x | -8.96x | -7.17x | -6.87x | -6.25x | -6.39x | -4.97x | - |
| Interest Coverage | - | 394.06x | 394.58x | 347.76x | 244.47x | 406.89x | 164.21x | -341.55x | 123.99x | 109.26x | 109.18x | 104.71x | 79.20x | 93.83x | 86.87x | 71.16x | 65.08x | 58.68x | 71.98x | -1.85x |
| Total Equity | 19.36B | 18.67B | 17.32B | 17.18B | 16.5B | 16.41B | 15.63B | 14.77B | 18.55B | 17.58B | 16.51B | 15.47B | 14.43B | 13.91B | 13.03B | 11.93B | 10.91B | 10.1B | 9.53B | 9.2B |
| Equity Growth % | 17.37% | 13.75% | 10.8% | 16.25% | -11.05% | -6.66% | -5.34% | -4.5% | 28.51% | 26.36% | 26.73% | 29.64% | 32.32% | 37.75% | 36.71% | 29.76% | 21.46% | 16.27% | 17.18% | 22.3% |
| Book Value per Share | 75.54 | 72.88 | 67.23 | 66.34 | 63.57 | 62.99 | 59.89 | 57.24 | 71.03 | 67.38 | 63.36 | 59.41 | 55.44 | 53.45 | 50.21 | 46.13 | 42.29 | 39.30 | 36.70 | 35.23 |
| Total Shareholders' Equity | 19.36B | 18.67B | 17.32B | 17.18B | 16.5B | 16.41B | 15.63B | 14.77B | 18.55B | 17.58B | 16.51B | 15.47B | 14.43B | 13.91B | 13.03B | 11.93B | 10.91B | 10.1B | 9.53B | 9.2B |
| Common Stock | 2.5M | 2.5M | 2.5M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.5M | 2.56M | 2.59M |
| Retained Earnings | 14.59B | 13.56B | 12.37B | 11.29B | 10.25B | 9.61B | 8.69B | 7.65B | 11.24B | 10.14B | 9.17B | 8.14B | 7.22B | 6.52B | 5.7B | 4.77B | 3.96B | 3.2B | 2.43B | 1.58B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 24.8M | -15.9M | -64.5M | -101.1M | 68.1M | 127.8M | 28.8M | 22.5M | 17.3M | -14.3M | -3M | -39.8M | -13.1M | 800K | 97.6M | 57.5M | 11.3M | 15.9M | 11.54M | -25.16M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |